FAP and cancer: The TMs used in this study are strategically engineered to target the fibroblast activation protein (FAP), a cell surface protein overexpressed in a broad spectrum of cancers[33] and, particularly, in cancer‐associated stromal cells, such as cancer‐associated fibroblasts, within the tumor microenvironment.